Research Paper Volume 14, Issue 2 pp 826—844
A new signature based on alternative polyadenylation for prognostic prediction and therapeutic responses in low-grade glioma
Figure 7. Estimation of the immune status and response to immunotherapy based on the signature in the high-risk and low-risk groups for the whole set. (A) Heatmap of the immune scores, stromal scores, tumor purity, ESTIMATE scores and immune-infiltrating cells in the two groups. (B–E) Violin plots for the immune scores, stromal scores, ESTIMATE scores, and tumor purity. (F–H) Boxplots of immune cells scores, immune-related functions scores and immune checkpoints expression. (I) Prediction of immunotherapy response according to TIDE score. *P < 0.05; **P < 0.01; ***P < 0.001; ns: no significance.